Catherine Shaffer - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Catherine Shaffer's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Catherine Shaffer
Verified
Reporter, Precision Oncology News
Ann Arbor
Beats
Content
By Catherine Shaffer Verified| Precision Medicine Online Verified NEW YORK – Johnson & Johnson CEO Joaquin Duato believes that Rybrevant (amivantamab) plus Lazcluze (lazertinib) will become the new standard of care in first-line EGFR-mutated advanced non-small cell lung cancer after the combination extended overall survival by more than a year, compared to AstraZeneca's Tagrisso (osimertinib) in a clinical trial.
By Catherine Shaffer Verified| Precision Medicine Online Verified NEW YORK – Following its acquisition of TigaTx earlier this week, Epsilogen is mulling its options for new biomarker-driven cancer therapeutics by leveraging new capabilities across three antibody isotypes. Epsilogen was founded in 2017 in London to advance antibodies for cancer based on immunoglobulin E (IgE). This focus set it apart from other companies developing antibody therapies, which have overwhelmingly built their drugs using immunoglobulin G (IgG).
By Catherine Shaffer Verified| Precision Medicine Online Verified NEW YORK – Johnson & Johnson CEO Joaquin Duato believes that Rybrevant (amivantamab) plus Lazcluze (lazertinib) will become the new standard of care in first-line EGFR-mutated advanced non-small cell lung cancer after the combination extended overall survival by more than a year, compared to AstraZeneca's Tagrisso (osimertinib) in a clinical trial.
Company Info
Precision Oncology News
GenomeWeb is an independent online news organization based in New York, established in 1997. It serves the global community of scientists, technology professionals, and executives involved in molecular biology research and molecular diagnostics. As a business unit of Crain Communications, GenomeWeb focuses on delivering comprehensive news coverage and in-depth analysis in the fields of genomics and molecular diagnostics. The organization operates the largest online newsroom dedicated to advanced molecular research tools, providing exclusive news and insights. Key offerings include detailed news and analysis of scientific advancements, premium content for subscribers, access to data centers and research reports, and newsletters to keep professionals updated on the latest developments. GenomeWeb's audience includes major scientific organizations, biopharmaceutical companies, research universities, and clinical labs, making it a vital resource in the genomics sector.
New York, New York, United States
+1 212-269-4747
Founded: 1997